Task: Answer the multiple-choice question.
Question: Which drug exhibits a -1.846% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
(a) COc1ccc(NC(=O)CN2CCN(Cc3ccccc3)CC2)cc1
(b) CN(c1ccccc1)S(=O)(=O)c1ccc(C(=O)Nc2ncccc2O)cc1
(c) C/C(CC(=O)NC1CCCC1)=N\NC(=O)c1ccc([N+](=O)[O-])c(Cl)c1
(d) O=C(CSc1nnc(-c2ccccc2O)o1)N1CCc2ccccc2C1
(e) COCC(=O)Nc1cc(C)cn(Cc2c(F)cccc2Cl)c1=O
Answer: b. CN(c1ccccc1)S(=O)(=O)c1ccc(C(=O)Nc2ncccc2O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(c1ccccc1)S(=O)(=O)c1ccc(C(=O)Nc2ncccc2O)cc1
CN(c1ccccc1)S(=O)(=O)c1ccc(C(=O)Nc2ncccc2O)cc1
N-(3-hydroxypyridin-2-yl)-4-[methyl(phenyl)sulfamoyl]benzamide